Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

QR Code

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

Direct-acting antivirals have become widely used for patients with chronic hepatitis C virus infection with decompensated cirrhosis. Virological responses are excellent and early improvements in liver function, at least in a proportion of patients, have been observed but the longer term impact of vi...

Full description

Bibliographic Details
Main Authors:	Cheung, Michelle C.M., Walker, Alex J., Hudson, Benjamin E., Verma, Suman, McLauchlan, John, Mutimer, David J., Brown, Ashley, Gelson, William T.H., MacDonald, Douglas C., Agarwal, Kosh, Foster, Graham R., Irving, William L.
Format:	Article
Published:	Elsevier 2016
Subjects:	Hepatitis C virus; Sofosbuvir; Ledipasvir; Daclatasvir; Decompensated cirrhosis; MELD score
Online Access:	https://eprints.nottingham.ac.uk/35008/

Similar Items

Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
by: Foster, Graham R., et al.
Published: (2016)

Causes of death in people with liver cirrhosis in England compared to the general population: a population-based cohort study
by: Ratib, Sonia, et al.
Published: (2015)

Liver cirrhosis in England--an observational study: are we measuring its burden occurrence correctly?
by: Ratib, Sonia, et al.
Published: (2017)

1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998–2009: a large population study
by: Ratib, Sonia, et al.
Published: (2014)

A validation study of the CirCom comorbidity score in an English cirrhosis population using the Clinical Practice Research Datalink
by: Crooks, Colin J., et al.
Published: (2018)

Hip fracture risk in patients with alcoholic cirrhosis: a population-based study using English and Danish data
by: Otete, Harmony E., et al.
Published: (2018)

Sex and age differences in the early identification and treatment of alcohol use: a population-based study of patients with alcoholic cirrhosis
by: Otete, Harmony E., et al.
Published: (2015)

Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study
by: West, Joe, et al.
Published: (2017)

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
by: Kendall, Timothy, et al.
Published: (2018)

Multi organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging
by: Bradley, Christopher R., et al.
Published: (2018)

Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using Transient Elastography
by: Harman, David J., et al.
Published: (2018)

The effects of probiotics and symbiotics on risk factors for hepatic encephalopathy
by: Viramontes Hörner, Daniela, et al.
Published: (2017)

Association between psychological distress and liver disease mortality: a meta-analysis of individual study participants
by: Russ, Tom C., et al.
Published: (2015)

Opportunities in UK primary and secondary healthcare settings to prevent alcohol misuse
by: Otete, Harmony Eroboghene
Published: (2016)

The identification of chronic liver disease in primary care using non-invasive diagnostics within a novel pathway
by: Harman, David J.
Published: (2017)

A conceptual model of compensation/decompensation in lumbar segmental instability
by: Barz, T., et al.
Published: (2014)

Antifibrotic Effect of Transforming Growth Factor Beta 1 Inhibitor Extract from Streptomyces SP.Strain H6552 on Human Hepatic Stellate Cells
by: Lim, Chooi Ling
Published: (2010)

The role of nt-probnp in assessing the control of decompensated heart failure patients
by: Shaban, Awf Abdulrahman
Published: (2013)

Management of Acute Decompensated Heart Failure in Rural Versus Metropolitan Settings: An Australian Experience
by: Chan, R.K., et al.
Published: (2022)

Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy?
by: Abo-zeid, Yasmin, et al.
Published: (2018)

Pretreatment lesions on magnetic resonance imaging in patients with hepatitis C virus infection diagnosed with hepatocellular carcinoma after initiating direct-acting antiviral therapy
by: Scott, Robert A., et al.
Published: (2018)

Iron and Hepatic Carcinogenesis
by: Tirnitz-Parker, Janina, et al.
Published: (2013)

An antiviral composition.
by: Abu Bakar, Fatimah, et al.
Published: (2011)

Cohort profile: the Hepatitis C Virus (HCV) Research UK clinical database and biobank
by: McLauchlan, John, et al.
Published: (2017)

SOX9 predicts progression towards cirrhosis in patients while its loss protects against liver fibrosis
by: Athwal, Varinder S., et al.
Published: (2017)

The epidemiology of cirrhosis and abnormal liver function in the general population of the UK
by: Fleming, Catherine Mary
Published: (2010)

Patient understanding of liver cirrhosis and improvement using multimedia education
by: Goldsworthy, Matthew A., et al.
Published: (2017)

Quantitative magnetic resonance imaging to evaluate patients with liver cirrhosis
by: Scott, Robert A.D.
Published: (2020)

Circular antiviral RNA
by: Omar, Abdul Rahman, et al.
Published: (2012)

An antiviral to cure patients
by: Tang, Ashley
Published: (2021)

Liver ultrasound does not accurately predict transient elastography diagnosed cirrhosis
by: Ranaweera, C., et al.
Published: (2014)

Comorbities and medications of patients with chronic hepatitis C under specialist care in the UK
by: Hudson, Benjamin, et al.
Published: (2017)

Tingkat penggunaan ubat antiviral
by: Halid, Suzalina
Published: (2022)

Role of therapeutic plasma exchange in severe thyrotoxicosis secondary to grave’s disease with several organ decompensation: a case report and review of literature
by: Rozi, Nur Raziana, et al.
Published: (2017)

A review with updated perspectives on the antiviral potentials of traditional medicinal plants and their prospects in antiviral therapy
by: Saifulazmi, Nur Fadlin, et al.
Published: (2022)

Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals
by: Simmons, Ruth, et al.
Published: (2017)

Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Occurrence of liver cirrhosis in England, a cohort study, 1998-2009: a comparison with cancer
by: Ratib, Sonia, et al.
Published: (2014)

Aetiologies of liver cirrhosis among adult patients attending a hepatology clinic at Selangor, Malaysia
by: Chieng, Jin Yu, et al.
Published: (2022)

Chemical constituents and antiviral study of Goniothalamus velutinus
by: Fasihuddin Badruddin,, Ahmad, et al.
Published: (2014)